In contrast, the expression of metallothionein-1 (MT1) is upregulated in different tumors, such as breast cancer, ovarian cancer, urinary bladder cancer, melanoma, and lung cancer [19]. This evidence concerns the gene MT1A and ovarian carcinoma.